These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 20429391)
1. [Medicines raw materials used in compounding medicines: an update of the legislation]. Huyghebaert C; Leuckx S J Pharm Belg; 2010 Mar; (1):16-8. PubMed ID: 20429391 [No Abstract] [Full Text] [Related]
2. [Manufacturing and control in pharmaceutical industry. Introduction into manufacturing control. Introduction]. Hippenmeier F Pharm Acta Helv; 1972; 47(11):625-8. PubMed ID: 4657531 [No Abstract] [Full Text] [Related]
3. [Maintaining standards of good compounding (N.B.F.)]. Castoldi B; Fumagalli A; Mazzoldi G Boll Chim Farm; 1978 Dec; 117(12):689-99. PubMed ID: 752351 [No Abstract] [Full Text] [Related]
4. Report on the PQRI impurity characterization and quantification best practices survey. Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396 [No Abstract] [Full Text] [Related]
5. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories. Jimenez FA Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711 [No Abstract] [Full Text] [Related]
6. GMPs vs GCPs: United States Pharmacopeia General Chapters. Allen LV Int J Pharm Compd; 2013; 17(5):439. PubMed ID: 24459791 [No Abstract] [Full Text] [Related]
7. WHO Expert Committee on Specifications for Pharmaceutical Preparations. World Health Organ Tech Rep Ser; 1999; 885():i-vi, 1-156. PubMed ID: 10352573 [TBL] [Abstract][Full Text] [Related]
8. The role of the European Pharmacopoeia. Artiges A Dev Biol Stand; 1992; 79():87-93. PubMed ID: 1286769 [No Abstract] [Full Text] [Related]
9. Pharmaceutical controls for drug availability. Bethel RF Med Serv J Can; 1967 Mar; 23(3):337-45. PubMed ID: 6061040 [No Abstract] [Full Text] [Related]
10. [Charter of medicines promotion and rational use by physicians]. Baumevieille M; Bégaud B; Maurain C Therapie; 2007; 62(1):39-44. PubMed ID: 17374346 [TBL] [Abstract][Full Text] [Related]
11. Proposed current good manufacturing practice and supplemental regulations. Korun FD Bull Parenter Drug Assoc; 1976; 30(3):139-42. PubMed ID: 1268432 [No Abstract] [Full Text] [Related]
12. PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing. Allen LV Int J Pharm Compd; 2018; 22(2):92. PubMed ID: 29877856 [No Abstract] [Full Text] [Related]
13. [Drug counterfeiting and counter measures. Study by the Hungarian National Alliance Against Drug Counterfeiting]. Psychiatr Hung; 2009; 24(3):205-14. PubMed ID: 20017282 [No Abstract] [Full Text] [Related]
14. Should the patent system for new medicines be abolished? DiMasi JA; Grabowski HG Clin Pharmacol Ther; 2007 Nov; 82(5):488-90. PubMed ID: 17952100 [No Abstract] [Full Text] [Related]
15. Therapeutic response in oral dosage forms. Morrison AB Med Serv J Can; 1967 Mar; 23(3):349-59. PubMed ID: 6056377 [No Abstract] [Full Text] [Related]
16. The future of USP monographs for PET drugs. Schwarz S; Norenberg J; Berridge M; Dragotakes S; Hung J; Link J; Mason NS; Mattmuller S; Nickel RA; Packard A; Paolino J; Petry N; Ponto J; Quinton TM; Seifert KL; Swanson D; Weiner RE; Zigler S J Nucl Med; 2013 Mar; 54(3):472-5. PubMed ID: 23264689 [No Abstract] [Full Text] [Related]
17. What is quality of medicines? Doogue MP; Thynne TR Intern Med J; 2013 Oct; 43(10):1057-8. PubMed ID: 24134167 [No Abstract] [Full Text] [Related]
18. Compounding pharmacy industry has outgrown its regulatory system, ASHP and FDA say. Thompson CA Am J Health Syst Pharm; 2013 May; 70(9):747-8. PubMed ID: 23592352 [No Abstract] [Full Text] [Related]